Nuzenio

Annamycin

Annamycin news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Moleculin reports promising preliminary phase II/III data for leukaemia drug Annamycin - Indian Pharma PostIndian Pharma Post · Tue, 04 Aug 2026 13:56:06 GMTMoleculin reports interim results from MIRACLE trial in r/r AML patients - Clinical Trials ArenaClinical Trials Arena · Mon, 03 Aug 2026 15:49:21 GMTMoleculin Biotech Reports Positive Pivotal Phase 2/3 Trial Results for Annamycin in AML - The Indian PractitionerThe Indian Practitioner · Mon, 03 Aug 2026 12:46:33 GMTMoleculin Biotech (MBRX US): Synthetic Expert Call Transcript (01 Aug 2026) - SmartkarmaSmartkarma · Sat, 01 Aug 2026 10:59:38 GMTMoleculin Biotech updates Annamycin data, prices stock offering at $0.75 - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sat, 01 Aug 2026 06:43:05 GMTMoleculin Biotech Stock Is Sinking Friday: What's Going On? - TradingViewTradingView · Fri, 31 Jul 2026 17:37:09 GMTMoleculin Biotech Prices Public Offering to Fund Clinical Development - Intellectia AIIntellectia AI · Fri, 31 Jul 2026 14:51:47 GMTMoleculin Biotech Prices $9.3 Million Best-Efforts Public Offering with Warrants - Quiver QuantitativeQuiver Quantitative · Fri, 31 Jul 2026 14:20:00 GMT

Timeline

Tue, 04 Aug 2026 13:56:06 GMTMoleculin reports promising preliminary phase II/III data for leukaemia drug Annamycin - Indian Pharma Post
Mon, 03 Aug 2026 15:49:21 GMTMoleculin reports interim results from MIRACLE trial in r/r AML patients - Clinical Trials Arena
Mon, 03 Aug 2026 12:46:33 GMTMoleculin Biotech Reports Positive Pivotal Phase 2/3 Trial Results for Annamycin in AML - The Indian Practitioner
Sat, 01 Aug 2026 10:59:38 GMTMoleculin Biotech (MBRX US): Synthetic Expert Call Transcript (01 Aug 2026) - Smartkarma
Sat, 01 Aug 2026 06:43:05 GMTMoleculin Biotech updates Annamycin data, prices stock offering at $0.75 - The Clinical Trial Vanguard
Fri, 31 Jul 2026 17:37:09 GMTMoleculin Biotech Stock Is Sinking Friday: What's Going On? - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Annamycin.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.